Secretin: Clinical Trials

8 trials of Secretin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 terminated. 8 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Unknown 2, Terminated 1
Phase 14Completed 2, Terminated 1, Unknown 1
Phase 32Completed 2

Follow Secretin: new trials by email Literature Review of Secretin trials Research Report on Secretin

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Secretin in Functional Dyspepsia and Healthy Subjects
Human Secretin, Placebo - Dyspepsia, Healthy
Phase 1 / Phase 2CompletedMayo Clinic202018-11-072020-06-11
Secretin for Acute Pancreatitis
Secretin - Pancreatitis, Acute
Phase 2UnknownChiRhoClin, Inc.402018-10-012019-04-10
Secretin Activates Human Brown Fat and Induces Satiation.
Secretin Human, Saline Solution, Cold exposure - Obesity
Phase 2 / Phase 3CompletedTurku University Hospital232016-08-022019-12-23
Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection
Secretin, Placebo - Injury of Body of Pancreas
Phase 2 / Phase 3CompletedDartmouth-Hitchcock Medical Center1702014-05-012020-03-31
Pancreatic Perfusion Using Secretin and MRI
Secretin - Chronic Pancreatitis
Phase 1 / Phase 2UnknownUniversity of Nottingham152012-06-012016-02-18
Secretin Infusion for Pain Due to Chronic Pancreatitis
Human Secretin - Chronic Pancreatitis
Phase 1 / Phase 2CompletedChiRhoClin, Inc.122010-12-012016-03-09
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Synthetic Human Secretin - Pancreatic Cancer
Phase 1 / Phase 2TerminatedMayo Clinic42006-11-012013-06-24
Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
RG1068 (Synthetic Human Secretin) - Obsessive Compulsive Disorder (OCD)
Phase 2CompletedIndiana University122005-02-012024-02-23

Conditions studied

Pancreatitis (2)  ·  Pancreatitis, Chronic (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Diabetes Mellitus (1)  ·  Dyspepsia (1)  ·  Obesity (1)  ·  Obsessive-Compulsive Disorder (1)  ·  Pancreatic Neoplasms (1)  ·  Peutz-Jeghers Syndrome (1)

Sponsors

ChiRhoClin, Inc. (2)  ·  Mayo Clinic (2)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Indiana University (1)  ·  Turku University Hospital (1)  ·  University of Nottingham (1)

Countries

United States (6)  ·  Finland (1)  ·  United Kingdom (1)

Top investigators

Anantha Shekhar, MD, PhD (1)  ·  John Simpson (1)  ·  Michael Camilleri (1)  ·  Naoki Takahashi, M.D. (1)  ·  Pirjo R Nuutila, MD,PhD (1)  ·  Timothy B Gardner, M.D. (1)  ·  Timothy B Gardner, MD (1)

Results publications

PMID 23548879, PMID 32036693, PMID 33602643, PMID 34158656, PMID 34806426, PMID 36764966

NIH funding

R01DK115950 (1), R01DK122280 (1), UL1TR002377 (1)